82 FR 4896 - Public Hearing: Strategic Partnerships To Enhance the Safety of Imported Foods: Capacity Building, Risk-Based Decisionmaking, Recognition of Commodity Food Control Programs, and Systems Recognition; Request for Comments
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration Federal Register Volume 82, Issue 10 (January 17, 2017)
Food and Drug Administration
Federal Register Volume 82, Issue 10 (January 17, 2017)
| Page Range | 4896-4899 | |
| FR Document | 2017-00821 |
[Federal Register Volume 82, Number 10 (Tuesday, January 17, 2017)] [Notices] [Pages 4896-4899] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-00821] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2016-N-4662] Public Hearing: Strategic Partnerships To Enhance the Safety of Imported Foods: Capacity Building, Risk-Based Decisionmaking, Recognition of Commodity Food Control Programs, and Systems Recognition; Request for Comments AGENCY: Food and Drug Administration, HHS. ACTION: Notice of public hearing; request for comments. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA or we) is announcing a public hearing regarding FDA initiatives for enhancing the safety of foods (for humans and animals) imported into the United States. The hearing will focus on partnerships to improve safety capabilities through capacity building; partnerships that incorporate information from private entities and foreign competent authorities to inform risk- based decisionmaking; partnerships that recognize commodity-specific export programs; and partnerships that recognize the robustness of a nation's entire food safety system. In addition, we are seeking information from a variety of viewpoints, including from competent authorities in other countries and from private entities, to help inform FDA regarding risk-based decisionmaking, commodity-specific export control programs in other countries, and systems recognition. DATES: See ``How to Participate in the Hearing'' in the SUPPLEMENTARY INFORMATION section of this document for dates and times of the public meetings, closing dates for advance registration, requesting special accommodations due to disability, closing date to submit comments to the docket, and other information regarding meeting participation. ADDRESSES: You may submit comments as follows: Electronic Submissions Submit electronic comments in the following way:Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https://www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else's Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov. If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see ``Written/Paper Submissions'' and ``Instructions''). Written/Paper Submissions Submit written/paper submissions as follows: Mail/Hand delivery/Courier (for written/paper submissions): Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. For written/paper comments submitted to the Division of Dockets Management, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in ``Instructions.'' Instructions: All submissions received must include the Docket No. FDA-2016-N-4662 for ``Public Hearing: Strategic Partnerships to Enhance the Safety of Imported Foods: Capacity Building, Risk-Based Decisionmaking, Recognition of Commodity Food Control Programs, and Systems Recognition.'' Received comments will be placed in the docket and, except for those submitted as ``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. Confidential Submissions--To submit a comment with confidential information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states ``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' We will review this copy, including the claimed confidential information, in our consideration of comments. The second copy, which will have the claimed confidential information redacted/blacked out, will be available for public viewing and posted on https://www.regulations.gov. Submit both copies to the Division of Dockets Management. If you do not wish your name and contact information to be made publicly available, you can provide this information on the cover sheet and not in the body of your comments and you must identify this information as ``confidential.'' Any information marked as ``confidential'' will not be disclosed except in accordance with 21 CFR 10.20 and other applicable disclosure law. For more information about FDA's posting of comments to public dockets, see 80 FR 56469, September 18, 2015, or access the information at: http://www.fda.gov/regulatoryinformation/dockets/default.htm. Docket: For access to the docket to read background documents or the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in the heading of this document, into the ``Search'' box and follow the prompts and/or go to the Division of Dockets Management, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. FOR FURTHER INFORMATION CONTACT: Wade Woolfolk, Food and Drug Administration, Center for Food Safety and Applied Nutrition (HFS-550), 5001 [[Page 4897]] Campus Dr., College Park, MD 20740, 240-402-6411, FAX: 301-436-2618, email: [email protected]. SUPPLEMENTARY INFORMATION: I. Background On March 30-31, 2011, we held a public hearing to discuss our use of international comparability assessments as a mechanism to help enhance the safety of imported foods (see ``Ensuring the Safety of Imported Foods and Animal Feed: Comparability of Food Safety Systems and Import Practices of Foreign Countries; Public Hearing; Request for Comments'' (76 FR 13638, March 14, 2011; available at https://www.regulations.gov, in docket FDA-2011-N-0135)). At the public hearing we presented information on our food safety capacity building efforts related to the FDA Food Safety Modernization Act (FSMA) (Pub. L. 111- 353). We also held a public meeting on June 19, 2012, to discuss our comprehensive plan to expand the technical, scientific, and regulatory capacity of foreign governments and their respective food industries in countries that export foods to the United States (see ``International Capacity Building with Respect to Food Safety Public Meeting'' (77 FR 30017, May 21, 2012; available at https://www.regulations.gov, in docket FDA-2011-N-0135)). This meeting invited discussion on the International Capacity Building plan development under FSMA. Following these discussions we issued the final International Capacity Building Plan in February 2013. See http://www.fda.gov/food/guidanceregulation/fsma/ucm301708.htm. FSMA has enabled us to better protect public health through new authorities to help ensure that imported foods meet the same safety standards as foods produced in the United States. In implementing FSMA, we recognize the importance of strengthening the existing collaborations among food safety regulators (U.S. Federal, State, local, territorial, tribal, and foreign) to achieve our public health goals. We continue to engage in a variety of partnerships that, collectively, are intended to enhance the safety of foods imported into the United States. At the public hearing that is the subject of this notice, we will provide an update on our food safety capacity building efforts, as well as additional updates and information on the approach we will use to help ensure the safety of imported foods. In addition, the public hearing will provide an opportunity for FDA to obtain testimony from diverse stakeholder groups as we seek to develop, expand, or refine key partnership activities. We seek input from a variety of perspectives on the following topics: How to expand performance measurement for FDA's capacity building activities to ensure that we collaborate effectively with other nations, multilateral organizations, donor organizations, and industry. How to operationalize the concept of ``same level of public health protection'' that is part of the rule on Foreign Supplier Verification Programs (FSVP) (80 FR 74226, November 27, 2015) and what types of partnerships facilitate application of this concept. (The FSVP regulation requires importers to implement FSVPs to provide adequate assurances that the importer's foreign suppliers produce food in compliance with processes and procedures, including risk-based preventive controls, that provide the same level of public health protection as those required under section 418 (concerning hazard analysis and preventive controls) or 419 (concerning produce safety) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act), as appropriate, and in compliance with sections 402 (concerning adulteration) and 403(w) (concerning misbranding regarding allergen labeling) of the FD&C Act.) Whether and how we should consider private standards in risk-based decisionmaking, including how other competent authorities use information, such as third-party certifications or other assurances, from private entities. Whether and how we should expand our systems recognition framework to include consideration of the recognition of commodity- specific export control programs. The initiatives that will be discussed at the public hearing align with and support FSMA implementation. Day one of the hearing will seek input on partnerships to improve food safety capabilities in other countries, tools to inform FDA's risk based decisionmaking, and methods to assess the effectiveness of our capacity building efforts. We also seek input on whether and how best to incorporate input from private entities and other competent authorities into our risk-based decisionmaking framework. Day two will seek input on partnerships that recognize the robustness of commodity-specific export programs including export certification programs and whether and how we should consider such programs. In addition, we seek input on the implementation of the systems recognition program. Interested parties may submit comments, data, and supporting information on the issues described in part II of this document. II. Purpose and Format of the Public Hearing A. Day One of Hearing 1. Partnerships To Improve Food Safety Capabilities: International Capacity Building Section 305 of FSMA requires the Secretary of Health and Human Services to develop a comprehensive plan to expand the technical, scientific, and regulatory food safety capacity of foreign governments, and their respective food industries, from which foods are exported to the United States. This authority was delegated to FDA, and we developed an International Food Safety Capacity Building Plan (the Plan). The Plan gives us a strategic framework to expand the technical, scientific, and regulatory capacity of foreign governments and their food industries. We developed the Plan in consultation with many partners, such as officials from other parts of the U.S. government; foreign government officials; non-governmental organizations (NGOs) that represent consumer interests; food industry representatives; and others. We seek input on successful models for continuing capacity building to further implement the plan. At this hearing, we will seek comment on food safety capacity building and development and invite comment, particularly publications and data, on food safety performance monitoring regimes; how donor organizations minimize duplication and support leveraged partnerships; how providers of training programs assure affordable, accessible, and culturally specific information is available to various regions of the world; how development agencies interface with food industry supply chain management programs; and whether we and industry can leverage each other's efforts. 2. Partnerships To Incorporate Information From Competent Authorities and Private Entities To Inform Risk-Based Decisionmaking In the Federal Register of November 27, 2015 (80 FR 74570), we published a final rule entitled, ``Accreditation of Third-Party Certification Bodies To Conduct Food Safety Audits and To Issue Certifications.'' The final rule established a voluntary program for the accreditation of third-party certification bodies to conduct food safety audits of foreign food facilities and to issue food and facility certifications. The requirements in the final rule will help [[Page 4898]] ensure the competence and independence of the accreditation bodies and third-party certification bodies participating in the program. We are aware that other countries incorporate information from private entities into their regulatory decisionmaking. We are interested in learning more about the policies, practices, and programs used by foreign regulators to ensure the safety of food imported into their countries. We seek comment and examples on how other countries use information from private entities; how other countries ensure parity in audit, inspectional, verification, and overall oversight between domestic and import activities; and how transparency can be best achieved. B. Day Two of Hearing 1. Partnerships That Recognize Commodity-Specific Exports and Programs We are interested in identifying successful models that recognize commodity specific food safety control systems (including export certification programs), how they are established, and how they operate. We seek comment and views on the best practices, strengths and weaknesses of commodity export programs or export certification systems; how commodity recognition programs factor into risk-based inspectional systems; and once adopted, how the programs are monitored over time. 2. Partnerships That Recognize the Robustness of the Entire Food Safety System: Systems Recognition FDA's systems recognition assessment process established in 2011 has progressed from a pilot to a robust program that has resulted in signed arrangements with New Zealand's Ministry for Primary Industries (2012) and Canada's Canadian Food Inspection Agency (CFIA) and the Department of Health Canada (Health Canada) (2016). We seek comment on what indicators we should consider to determine whether the program meets expected outcomes and best practices on how to identify robust food safety systems. III. Notice of Hearing Under Part 15 The Commissioner of Food and Drugs (the Commissioner) is announcing that the public hearing will be held in accordance with part 15 (21 CFR part 15). The hearing will be conducted by a presiding officer(s), accompanied by FDA senior management and staff from the relevant centers/offices (FDA panelists/experts). Under Sec. 15.30(f), the hearing is informal, and the rules of evidence do not apply. We encourage interested parties to submit comments to the docket. We also have invited certain members of the public to participate as guest presenters. Only the presiding officer(s) and FDA panelists/experts may question any person during or at the conclusion of each presentation by the FDA and guest presenters (Sec. 15.30(e)). At their discretion, the presiding officer(s) may permit questions to be submitted from the audience for response by FDA or other persons attending the hearing (Sec. 15.30(e)). Finally, time permitting, stakeholders may be allowed to provide testimony at the hearing. Time will be limited to 2 minutes and requests to make an oral presentation must be written and received by February 8, 2017. Please include the details of your presentation when making your request. All testimony will be entered into the docket. Public hearings under part 15 are subject to FDA's policy and procedures for electronic media coverage of FDA's public administrative proceedings (21 CFR part 10, subpart C) (Sec. 10.203(a)). Under Sec. 10.205, representatives of the electronic media may be permitted, subject to certain limitations, to videotape, film, or otherwise record FDA's public administrative proceedings, including presentations by participants. The hearing will be transcribed as stipulated in Sec. 15.30(b) (see part IV of this document). To the extent that the conditions for the hearing as described in this document conflict with any provisions set out in part 15, this notice acts as a waiver of those provisions as specified in Sec. 15.30(h). Comments may also be submitted after the hearing. The docket will remain open for such comments until May 16, 2017. IV. How To Participate in the Public Hearing Advance registration by submission of a notice of participation is necessary to ensure participation and will be accepted on a first-come, first-served basis. Notices of participation may be submitted electronically (see table 1 of this document); FDA encourages the use of electronic means of advance registration. Notices of participation may also be submitted orally or by mail, fax, or email (see FOR FURTHER INFORMATION CONTACT). See table 1 of this document for the dates by which notices of participation must be submitted. A single copy of any notice of participation is sufficient. Table 1 of this document provides information on participation in the public meetings. Table 1--Information on Participation in the Meeting -------------------------------------------------------------------------------------------------------------------------------------------------------- Activity Date Electronic address Address Other information -------------------------------------------------------------------------------------------------------------------------------------------------------- Attend Public Hearing............... February 14-15, 2017, Please preregister at www.fda.gov/Food/ FDA Center for Food Registration check-in from 9 a.m. to 5:00 NewsEvents/Workshops/Meetings/ Safety and Applied begins at 8 a.m. p.m. Conferences/default.htm. Nutrition, Wiley Auditorium, 5001 Campus Dr., College Park, MD 20740. View Webcast........................ February 14-15, 2017, Individuals who wish to participate by We encourage you to The Webcast will have from 9 a.m. to 5:00 Webcast are asked to preregister at use electronic closed captioning. p.m. www.fda.gov/Food/NewsEvents/ registration if WorkshopsMeetings/Conferences/ possible. default.htm. Advance registration................ Register by February 8, www.fda.gov/Food/NewsEvents/Workshops/ We encourage you to There is no 2017. Meetings Conferences/default.htm. use electronic registration fee for registration if the public hearing. possible \1\. Early registration is recommended because seating is limited.\1\ [[Page 4899]] Request to make an oral presentation Request by February 8, Individuals who wish to make a public See FOR FURTHER 2017. comment during the designated times in INFORMATION CONTACT. the hearing are asked to submit request and presentation at [email protected]. Submitting either electronic or Submit all other https://www.regulations.gov.............. Division of Dockets See ADDRESSES for written comments. comments by May 16, Management (HFA-305), information on 2017. Food and Drug submitting comments. Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. Request special accommodations due Request by February 8, Wade Woolfolk, email: See FOR FURTHER to a disability. 2017. [email protected]. INFORMATION CONTACT. -------------------------------------------------------------------------------------------------------------------------------------------------------- \1\ Onsite registration will not be available at the meeting site. V. Transcripts Please be advised that as soon as a transcript is available, it will be accessible at https://www.regulations.gov. It may be viewed at the Division of Dockets Management (see ADDRESSES). A transcript will also be available in either hardcopy or on CD-ROM, after submission of a Freedom of Information request. The Freedom of Information office address is available on FDA's Web site at http://www.fda.gov. Dated: January 11, 2017. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2017-00821 Filed 1-13-17; 8:45 am] BILLING CODE 4164-01-P
![4896 Federal Register / Vol. 82, No. 10 / Tuesday, January 17, 2017 / Notices
recommendations on how to accurately variety of viewpoints, including from Instructions: All submissions received
use these terms in an ANDA, how competent authorities in other countries must include the Docket No. FDA–
persons can request FDA designation of and from private entities, to help inform 2016–N–4662 for ‘‘Public Hearing:
an RLD, and how persons can request FDA regarding risk-based Strategic Partnerships to Enhance the
FDA selection of a reference standard. decisionmaking, commodity-specific Safety of Imported Foods: Capacity
This draft guidance is being issued export control programs in other Building, Risk-Based Decisionmaking,
consistent with FDA’s good guidance countries, and systems recognition. Recognition of Commodity Food Control
practices regulation (21 CFR 10.115). DATES: See ‘‘How to Participate in the Programs, and Systems Recognition.’’
The draft guidance, when finalized, will Hearing’’ in the SUPPLEMENTARY Received comments will be placed in
represent the current thinking of FDA INFORMATION section of this document the docket and, except for those
on Referencing Approved Drug Products for dates and times of the public submitted as ‘‘Confidential
in ANDA Submissions. It does not meetings, closing dates for advance Submissions,’’ publicly viewable at
establish any rights for any person and registration, requesting special https://www.regulations.gov or at the
is not binding on FDA or the public. accommodations due to disability, Division of Dockets Management
You can use an alternative approach if closing date to submit comments to the between 9 a.m. and 4 p.m., Monday
it satisfies the requirements of the docket, and other information regarding through Friday.
applicable statutes and regulations. meeting participation. • Confidential Submissions—To
II. Electronic Access ADDRESSES: You may submit comments
submit a comment with confidential
as follows: information that you do not wish to be
Persons with access to the Internet made publicly available, submit your
may obtain the draft guidance at either Electronic Submissions comments only as a written/paper
http://www.fda.gov/Drugs/Guidance submission. You should submit two
ComplianceRegulatoryInformation/ Submit electronic comments in the
following way: copies total. One copy will include the
Guidances/default.htm or https://
• Federal eRulemaking Portal: information you claim to be confidential
www.regulations.gov.
https://www.regulations.gov. Follow the with a heading or cover note that states
Dated: January 11, 2017. ‘‘THIS DOCUMENT CONTAINS
instructions for submitting comments.
Leslie Kux, CONFIDENTIAL INFORMATION.’’ We
Comments submitted electronically,
Associate Commissioner for Policy. including attachments, to https:// will review this copy, including the
[FR Doc. 2017–00820 Filed 1–13–17; 8:45 am] www.regulations.gov will be posted to claimed confidential information, in our
BILLING CODE 4164–01–P the docket unchanged. Because your consideration of comments. The second
comment will be made public, you are copy, which will have the claimed
solely responsible for ensuring that your confidential information redacted/
DEPARTMENT OF HEALTH AND comment does not include any blacked out, will be available for public
HUMAN SERVICES confidential information that you or a viewing and posted on https://
third party may not wish to be posted, www.regulations.gov. Submit both
Food and Drug Administration copies to the Division of Dockets
such as medical information, your or
[Docket No. FDA–2016–N–4662] anyone else’s Social Security number, or Management. If you do not wish your
confidential business information, such name and contact information to be
Public Hearing: Strategic Partnerships as a manufacturing process. Please note made publicly available, you can
To Enhance the Safety of Imported that if you include your name, contact provide this information on the cover
Foods: Capacity Building, Risk-Based information, or other information that sheet and not in the body of your
Decisionmaking, Recognition of identifies you in the body of your comments and you must identify this
Commodity Food Control Programs, comments, that information will be information as ‘‘confidential.’’ Any
and Systems Recognition; Request for posted on https://www.regulations.gov. information marked as ‘‘confidential’’
Comments • If you want to submit a comment will not be disclosed except in
with confidential information that you accordance with 21 CFR 10.20 and other
AGENCY: Food and Drug Administration,
do not wish to be made available to the applicable disclosure law. For more
HHS.
public, submit the comment as a information about FDA’s posting of
ACTION:Notice of public hearing; request comments to public dockets, see 80 FR
for comments. written/paper submission and in the
manner detailed (see ‘‘Written/Paper 56469, September 18, 2015, or access
SUMMARY: The Food and Drug Submissions’’ and ‘‘Instructions’’). the information at: http://www.fda.gov/
Administration (FDA or we) is regulatoryinformation/dockets/
announcing a public hearing regarding Written/Paper Submissions default.htm.
FDA initiatives for enhancing the safety Submit written/paper submissions as Docket: For access to the docket to
of foods (for humans and animals) follows: read background documents or the
imported into the United States. The • Mail/Hand delivery/Courier (for electronic and written/paper comments
hearing will focus on partnerships to written/paper submissions): Division of received, go to https://
improve safety capabilities through Dockets Management (HFA–305), Food www.regulations.gov and insert the
capacity building; partnerships that and Drug Administration, 5630 Fishers docket number, found in brackets in the
incorporate information from private Lane, Rm. 1061, Rockville, MD 20852. heading of this document, into the
entities and foreign competent • For written/paper comments ‘‘Search’’ box and follow the prompts
sradovich on DSK3GMQ082PROD with NOTICES
authorities to inform risk-based submitted to the Division of Dockets and/or go to the Division of Dockets
decisionmaking; partnerships that Management, FDA will post your Management, 5630 Fishers Lane, Rm.
recognize commodity-specific export comment, as well as any attachments, 1061, Rockville, MD 20852.
programs; and partnerships that except for information submitted, FOR FURTHER INFORMATION CONTACT:
recognize the robustness of a nation’s marked and identified, as confidential, Wade Woolfolk, Food and Drug
entire food safety system. In addition, if submitted as detailed in Administration, Center for Food Safety
we are seeking information from a ‘‘Instructions.’’ and Applied Nutrition (HFS–550), 5001
VerDate Sep<11>2014 18:21 Jan 13, 2017 Jkt 241001 PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 E:\FR\FM\17JAN1.SGM 17JAN1](https://thefederalregister.org/doc/82_FR_4906/page/1.svg)
![Federal Register / Vol. 82, No. 10 / Tuesday, January 17, 2017 / Notices 4899
TABLE 1—INFORMATION ON PARTICIPATION IN THE MEETING—Continued
Activity Date Electronic address Address Other information
Request to make an oral Request by February 8, Individuals who wish to See FOR FURTHER IN-
presentation. 2017. make a public comment FORMATION CON-
during the designated TACT.
times in the hearing are
asked to submit request
and presentation at
IASEvents@fda.hhs.gov.
Submitting either electronic Submit all other comments https://www.regulations.gov Division of Dockets Man- See ADDRESSES for in-
or written comments. by May 16, 2017. agement (HFA–305), formation on submitting
Food and Drug Adminis- comments.
tration, 5630 Fishers
Lane, Rm. 1061, Rock-
ville, MD 20852.
Request special accom- Request by February 8, Wade Woolfolk, email: See FOR FURTHER IN-
modations due to a dis- 2017. wade.woolfolk@ FORMATION CON-
ability. fda.hhs.gov. TACT.
1 Onsite registration will not be available at the meeting site.
V. Transcripts public review of this ICR will be clinical aspects of transplantation,
Please be advised that as soon as a provided to OMB. OMB will accept participate in the Hospital Campaign to
transcript is available, it will be further comments from the public provide assistance to hospitals in their
accessible at https:// during the review and approval period. service areas as they implement
www.regulations.gov. It may be viewed DATES: Comments on this ICR should be strategies and activities to increase the
at the Division of Dockets Management received no later than February 16, number of enrollments in state donor
(see ADDRESSES). A transcript will also 2017. registries. HRSA supports the Hospital
be available in either hardcopy or on Campaign by providing
ADDRESSES: Submit your comments,
CD–ROM, after submission of a communications materials, facilitating
including the Information Collection
Freedom of Information request. The the sharing of best practices, leveraging
Request Title, to the desk officer for
Freedom of Information office address is the influence of national associations
HRSA, either by email to OIRA_
available on FDA’s Web site at http:// and organizations related to hospitals
submission@omb.eop.gov or by fax to
www.fda.gov. and organ donation as Campaign
202–395–5806.
National Partners, and offering the
Dated: January 11, 2017. FOR FURTHER INFORMATION CONTACT: To additional incentive of national-level
Leslie Kux, request a copy of the clearance requests recognition to hospitals.
Associate Commissioner for Policy. submitted to OMB for review, email the Need and Proposed Use of the
[FR Doc. 2017–00821 Filed 1–13–17; 8:45 am] HRSA Information Collection Clearance Information: The Hospital Campaign’s
BILLING CODE 4164–01–P
Officer at paperwork@hrsa.gov or call Activity Scorecard is a key component
(301) 443–1984. of this effort. It provides a menu of over
SUPPLEMENTARY INFORMATION: 40 ideas for outreach activities. The
DEPARTMENT OF HEALTH AND Information Collection Request Title: Activity Scorecard also provides
HUMAN SERVICES National Hospital Organ Donation incentive for hospitals to participate by
Campaign’s Activity Scorecard OMB laying the foundation for recognition.
Health Resources and Services No. 0915–0373—Revision. Each activity on the programmable PDF
Administration Abstract: HRSA’s Healthcare Systems is assigned a particular number of
Bureau, Division of Transplantation, points based on the activity’s potential
Agency Information Collection administers the Workplace Partnership for generating registrations. Recognition
Activities: Submission to OMB for for Life (WPFL) program under the is awarded to hospitals that have annual
Review and Approval; Public Comment authority of Section 377A(a) of the points which qualify them for one of the
Request; National Hospital Organ Public Health Service (PHS) Act, (42 following recognition levels: bronze,
Donation Campaign’s Activity U.S.C. 274f–1). The WPFL seeks to silver, gold, and platinum.
Scorecard involve workplaces and other Hospitals can complete the Activity
AGENCY: Health Resources and Services organizations in a national effort to Scorecard and submit it annually via
Administration (HRSA), Department of increase the number of registered organ, email or fax to HRSA or to their local
Health and Human Services. eye, and tissue donors and to increase OPO or Donate Life America (DLA)
ACTION: Notice. awareness about organ donation. In affiliate to be considered for recognition.
2011, HRSA launched the National This is a voluntary activity and
SUMMARY: In compliance with the Hospital Organ Donation Campaign hospitals may participate in the
requirement for opportunity for public (Hospital Campaign) and issued a
sradovich on DSK3GMQ082PROD with NOTICES
campaign without using or submitting a
comment on proposed data collection challenge to hospitals nationwide to completed Activity Scorecard. However,
projects of the Paperwork Reduction Act assist in this effort by conducting donor most hospitals enrolled in the campaign
of 1995, HRSA has submitted an education and donor registry enrollment (currently 2,038) have submitted a
Information Collection Request (ICR) to events in their hospitals and completed Activity Scorecard to become
the Office of Management and Budget communities. The nation’s 58 organ eligible for recognition.
(OMB) for review and approval. procurement organizations (OPOs), Hospitals that achieve specific
Comments submitted during the first which already work with hospitals on outlined levels are recognized annually
VerDate Sep<11>2014 18:21 Jan 13, 2017 Jkt 241001 PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 E:\FR\FM\17JAN1.SGM 17JAN1](https://thefederalregister.org/doc/82_FR_4906/page/4.svg)
Document Created: 2017-01-14 01:44:28
Document Modified: 2017-01-14 01:44:28
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of public hearing; request for comments. | |
| Dates | See ``How to Participate in the Hearing'' in the SUPPLEMENTARY INFORMATION section of this document for dates and times of the public meetings, closing dates for advance registration, requesting special accommodations due to disability, closing date to submit comments to the docket, and other information regarding meeting participation. | |
| Contact | Wade Woolfolk, Food and Drug Administration, Center for Food Safety and Applied Nutrition (HFS-550), 5001 Campus Dr., College Park, MD 20740, 240-402-6411, FAX: 301-436-2618, email: [email protected] | |
| FR Citation | 82 FR 4896 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR